Artelo Biosciences
ARTL
12 hedge funds and large institutions have $2.17M invested in Artelo Biosciences in 2021 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 1 closing their positions.
800% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 1
785% more capital invested
Capital invested by funds: $245K → $2.17M (+$1.92M)
200% more funds holding
Funds holding: 4 → 12 (+8)
6.25% more ownership
Funds ownership: 2.22% → 8.47% (+6.2%)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$392K |
| 2 |
BFM
Boothbay Fund Management
New York
|
+$369K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$285K |
| 4 |
VF
Virtu Financial
New York
|
+$242K |
| 5 |
Bank of New York Mellon
New York
|
+$162K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KC
Kepos Capital
New York
|
-$80.8K |
| 2 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$9K |
ARTL Hedge Fund Activity: Q1 2021 in Review
12 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Artelo Biosciences (ARTL) for Q1 2021, worth a combined $2.17M — up 785% from $245K a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new ARTL positions and 1 closed out — a net gain of 8 holders — while 1 added to existing stakes and 1 trimmed.
The largest buyer was Vanguard Group, opening a new position worth an estimated $392K. The largest seller was Kepos Capital, cutting an estimated $80.8K.
- 12 institutional investors held Artelo Biosciences (ARTL) as of Q1 2021, up from 4 in Q4 2020.
- Funds reported $2.17M of Artelo Biosciences stock for Q1 2021, up 785% quarter-over-quarter.
- 9 funds opened new Artelo Biosciences positions in Q1 2021 and 1 closed out, a net change of +8 holders.
- The largest Artelo Biosciences buyer in Q1 2021 was Vanguard Group, an estimated $392K added.
- The largest Artelo Biosciences seller in Q1 2021 was Kepos Capital, an estimated $80.8K sold.
Based on aggregated 13F filings for Q1 2021.